LV

Lupus Ventures

Europe, Friesland, The Netherlands, Heerenveen

Description

Lupus Ventures is a Netherlands-based principal investment company specializes in biotechnology sector focused on oncology.

Investor Profile

Lupus Ventures has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Seed, Series A rounds (top funding stages).
  • Majority of deals are located in The Netherlands.
  • Strong thematic focus on Biotechnology, Chemical, Life Science.

Stage Focus

  • Series B (33%)
  • Seed (33%)
  • Series A (33%)

Country Focus

  • The Netherlands (100%)

Industry Focus

  • Biotechnology
  • Chemical
  • Life Science
  • Therapeutics
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lupus Ventures frequently co-invest with?

TF
Europe, Flevoland, The Netherlands, Lelystad
Co-Investments: 2
PPM Oost NV
Europe, Gelderland, The Netherlands, Apeldoorn
Co-Investments: 2
WB
Europe, Gelderland, The Netherlands, Wageningen
Co-Investments: 1
MKB & Technofonds Flevoland
Europe, Flevoland, The Netherlands, Lelystad-haven
Co-Investments: 1
Co-Investments: 2

What are some of recent deals done by Lupus Ventures?

Immunovo

's-hertogenbosch, Noord-Brabant, The Netherlands

Immunovo is operate as a biotechnology company to develop technology to create immunotherapeutic drugs

BiotechnologyPharmaceutical
SeedApr 28, 2010
Pepscan

Lelystad, Flevoland, The Netherlands

Pepscan employs protein mimicry techniques for the R&D of therapeutic drugs and a range of specialty peptide products and services.

BiotechnologyChemicalLife ScienceTherapeutics
Series BSep 19, 2006
Amount Raised: $8,872,901
Pepscan

Lelystad, Flevoland, The Netherlands

Pepscan employs protein mimicry techniques for the R&D of therapeutic drugs and a range of specialty peptide products and services.

BiotechnologyChemicalLife ScienceTherapeutics
Series AJul 8, 2005
Amount Raised: $5,968,489